Graph Therapeutics Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$5M
- Investors
-
8
Graph Therapeutics General Information
Description
Developer of AI-driven precision medicine designed for perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. The company leverages artificial intelligence to analyze a patient's unique biology to create personalized treatment plans for immune-mediated diseases, enabling the healthcare industry to overcome the unique challenges of developing therapies for complex inflammatory diseases.
Contact Information
Website
www.graphtx.comCorporate Office
- Xista Science Park, Plöcking 1
- Klosterneuburg, 3400
- Austria
Corporate Office
- Xista Science Park, Plöcking 1
- Klosterneuburg, 3400
- Austria
Graph Therapeutics Timeline
Graph Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC | 22-Jun-2026 | $5M | Completed | Generating Revenue | ||
| 3. Grant | 22-Apr-2025 | Completed | Generating Revenue | |||
| 2. Grant | 03-Mar-2025 | $1.15M | $3.1M | Completed | Generating Revenue | |
| 1. Seed Round | 09-Jan-2025 | $3.1M | $3.1M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Graph Therapeutics Comparisons
Industry
Financing
Details
Graph Therapeutics Competitors (3)
One of Graph Therapeutics’s 3 competitors is Relation Therapeutics, a Venture Capital-Backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Relation Therapeutics | Venture Capital-Backed | London, United Kingdom | ||||
| Owkin | Venture Capital-Backed | Paris, France | ||||
| Recursion AI | Corporation | Palo Alto, CA |
Graph Therapeutics Signals
Graph Therapeutics Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Daphni | Venture Capital | Minority | ||
| Austria Wirtschaftsservice | Venture Capital | Minority | ||
| Österreichische Forschungsförderungsgesellschaft | Government | |||
| Angel (individual) | Minority | |||
| Merantix Capital | Venture Capital | Minority |
Graph Therapeutics FAQs
-
When was Graph Therapeutics founded?
Graph Therapeutics was founded in 2024.
-
Where is Graph Therapeutics headquartered?
Graph Therapeutics is headquartered in Klosterneuburg, Austria.
-
What is the size of Graph Therapeutics?
Graph Therapeutics has 15 total employees.
-
What industry is Graph Therapeutics in?
Graph Therapeutics’s primary industry is Drug Discovery.
-
Is Graph Therapeutics a private or public company?
Graph Therapeutics is a Private company.
-
What is Graph Therapeutics’s current revenue?
The current revenue for Graph Therapeutics is .
-
How much funding has Graph Therapeutics raised over time?
Graph Therapeutics has raised $8.1M.
-
Who are Graph Therapeutics’s investors?
Daphni, Austria Wirtschaftsservice, Österreichische Forschungsförderungsgesellschaft, , and Merantix Capital are 5 of 8 investors who have invested in Graph Therapeutics.
-
Who are Graph Therapeutics’s competitors?
Relation Therapeutics, Owkin, and Recursion AI are competitors of Graph Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process